Search
Haleon PLC
HLNAdd to Watchlist
8.960USD
+0.090+1.01%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
39.90BMarket Cap
32.52P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Haleon PLC is 7.60, ranking 98 out of 157 in the Pharmaceuticals industry. The average price target is 11.50, with a high of 13.44 and a low of 5.88.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
10.670
Target Price
+19.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Haleon PLC
HLN
5
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Haleon PLC's price target?
Analysts forecast that Haleon PLC's price target is USD 11.50, with the highest forecast at USD 13.44 and the lowest forecast at USD 5.88.
What is the analyst rating for Haleon PLC?
Based on the ratings of Haleon PLC's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
